Patient care interventions to helpreduce the risk of surgical site infections

AORN Journal

Volumn 100, Issue 6, 2014, Pages 590-602

  Edmiston, Charles E ^a   Spencer, Maureen ^b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b Infection Prevention Consultants   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

EVIDENCE BASED MEDICINE; HUMAN; INCIDENCE; RISK REDUCTION; SURGICAL WOUND INFECTION; UNITED STATES;

ANTI-BACTERIAL AGENTS; EVIDENCE-BASED MEDICINE; HUMANS; INCIDENCE; RISK REDUCTION BEHAVIOR; SURGICAL WOUND INFECTION; UNITED STATES;

EID: 84912057718     PISSN: 00012092     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.aorn.2014.10.008     Document Type: Article

References (63)

1. National Healthcare Safety Network (NHSN). Accessed September 17,2014. http://www.cdc.gov/nhsn.
2. Healthcare-associated Infections (HAI) Progress Report. Centers for Disease Control and Prevention. Accessed September 16,2014. http://www.cdc.gov/hai/progress-report.
3. National and State Healthcare-Associated Infections Standardized Infection Ratio Report: Using Data Reported to the National Healthcare Safety Network. Accessed September 17,2014. http://www.cdc.gov/HAI/pdfs/SIR/national-SIR-Report_03_29_2012.pdf.
4. HAI prevention. Healthcare-associated infections (HAI). Wisconsin Department of Health Services. Published August 21, 2014. Accessed October 6,2014. http://www.dhs.wisconsin.gov/communicable/HAI/Index.htm.
5. Medicare program; hospital inpatient prospective payment systems for acute care hospitals and the long-term care hospital prospective payment system and fiscal year 2015 rates; quality reporting requirements for specific providers; reasonable compensation equivalents for physician services in excluded hospitals and certain teaching hospitals; provider administrative appeals and judicial review; enforcement provisions for organ transplant centers; and electronic health record (EHR) incentive program. Final rule. Fed Regist 2014, 79(163):49853-50536. Centers for Medicare & Medicaid Services (CMS), HHS.
6. Rasouli M.R., Jaberi M.M., Hozack W.J., Parvizi J., Rothman R.H. Surgical Care Improvement Project (SCIP): has its mission succeeded?. JArthroplasty 2013, 28(7):1072-1075.
7. Young H., Knepper B., Vigil C., Miller A., Carey J.C., Price C.S. Sustained reduction in surgical site infection after abdominal hysterectomy. Surg Infect 2013, 14(5):460-463.
8. Waits S.A., Fritze D., Banerjee M., et al. Developing an argument for bundle interventions to reduce surgical site infection in colorectal surgery. Surgery 2014, 155(4):602-606.
9. Belkin N.L. Use of scrubs and related apparel in health care facilities. Am J Infect Control 1997, 25(5):401-404.
10. Callaghan I. Bacterial contamination of nurses' uniforms: a study. Nurs Stand 1998, 13(1):37-42.
11. Neely A.N., Maley M.P. Survival of enterococci and staphylococci on hospital fabrics and plastic. JClin Microbiol 2002, 38(2):724-726.
12. Friberg B., Friberg S., Ostensson R., Burman L.G. Surgical area contamination-comparable bacterial counts using disposable head and mask and helmet aspirator system, but dramatic increase upon omission of head-gear: an experimental study in horizontal laminar air-flow. JHosp Infect 2001, 47(2):110-115.
13. Recommended practices for surgical attire. Perioperative Standards and Recommended Practices 2011, 57-72. AORN, Inc, Denver, CO.
14. Braswell M., Spruce L. Implementing AORN recommended practices for surgical attire. AORN J 2012, 95(1):122-137.
15. Dineen P., Drusin L. Epidemics of postoperative wound infections associated with hair carriers. Lancet 1973, 2(7839):1157-1159.
16. Mastro T.D., Farley T.A., Elliott J.A., et al. An outbreak of surgical-wound infections due to group A streptococcus carried on the scalp. NEngl J Med 1990, 323(14):968-972.
17. Boyce J.M. Evidence in support of covering the hair of or personnel. AORN J 2014, 99(1):4-8. [Guest Editorial].
18. Loftus R.W., Muffly M.K., Brown J.R., et al. Hand contamination of anesthesia providers is an important risk factor for intraoperative bacterial transmission. Anesth Analg 2011, 112(1):98-105.
19. Loftus R.W., Koff M.D., Burchman C.C., et al. Transmission of pathogenic bacterial organisms in the anesthesia work area. Anesthesiology 2008, 109(3):399-407.
20. Munoz-Price L.S., Arheart K.L., Mills J.P., et al. Associations between bacterial contamination of health care workers' hands and contamination of white coats and scrubs. Am J Infect Control 2012, 40(9):e245-e248.
21. Recommended practices for hand hygiene in the perioperative setting. Perioperative Standards and Recommended Practices 2011, 73-86. AORN, Inc, Denver, CO.
22. Belda F.J., Aguilera L., García de la Asunción J., et al. Supplemental perioperative oxygen and the risk of surgical wound infection: a randomized controlled trial. JAMA 2005, 294(16):2035-2042.
23. Wang Z.X., Jiang C.P., Cao Y., et al. Systematic review and meta-analysis of triclosan-coated sutures for the prevention of surgical-site infection. Br J Surg 2013, 100(4):465-473.
24. Edmiston C.E., Daoud F.C., Leaper D. Is there an evidence-based argument for embracing an antimicrobial (triclosan)-coated suture technology to reduce the risk of surgical site infections?: a meta-analysis. Surgery 2013, 154(1):89-100.
25. Daoud F., Edmiston C.E., Leaper D. Meta-analysis of prevention of surgical site infections following incision closure with triclosan-coated sutures: robustness of new evidence. Surg Infect 2014, 15(3):165-181.
26. Singh A., Bartysch S.M., Muder R.R., Lee B.Y. An economic model: value of antimicrobial-coated sutures to society, hospitals, and third-party payers in preventing abdominal surgical site infections. Infect Control Hosp Epidemiol 2014, 35(8):1013-1020.
27. Mangram A.J., Horan T.C., Pearson M.L., Silver L.C., Jarvis W.R. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1999, 20(4):250-278.
28. Webster J., Osborne S. Preoperative bathing or showering with skin antiseptics to prevent surgical site infection. Cochrane Database Syst Rev 2012, 9:CD004985.
29. Edmiston C.E., Krepel C.J., Seabrook G.T., et al. Preoperative shower revisited: can high topical antiseptic levels be achieved on the skin surface before surgical admission?. JAm Coll Surg 2008, 207(2):233-239.
30. Edmiston C.E., Okoli O., Graham M.B., Sinski S., Seabrook G.R. Evidence for using chlorhexidine gluconate preoperative cleansing to reduce the risk of surgical site infection. AORN J 2010, 92(5):509-518.
31. Edmiston C.E., Krepel C.J., Edmiston S.E., et al. Empowering the surgical patient: a randomized, prospective analysis of an innovative strategy for improving patient compliance with preadmission showering protocol. JAm Coll Surg 2014, 219(2):256-264.
32. Edmiston C.E., Krepel C., Kelly H., et al. Perioperative antibiotic prophylaxis in the gastric bypass patient: do weachieve therapeutic levels?. Surgery 2004, 136(4):738-747.
33. Pevzner L., Swank M., Krepel C., Wing D.A., Chan K., Edmiston C.E. Effects of maternal obesity on tissue concentrations of prophylactic cefazolin during cesarean delivery. Obstet Gynecol 2011, 117(4):877-882.
34. Waisbren E., Rosen H., Bader A.M., et al. Percent body fat and prediction of surgical site infection. JAm Coll Surg 2010, 210(4):381-389.
35. Borracci T., Adembri C., Accetta G., et al. Use of the parenteral antibiotic ertapenem as short term prophylaxis in bariatric surgery: a pharmacokinetic-pharmacodynamic study in class III obese female patients. Minerva Anestesiol 2014, 80(9):1005-1011.
36. Bratzler D.W., Dellinger E.P., Olsen K.M., et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health-Syst Pharm 2013, 70(3):195-283.
37. Kluytmans J., van Belkum A., Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 1997, 10(3):505-520.
38. Kim D.H., Spencer M., Davidson S.M., et al. Institutional prescreening for detection and eradication of methicillin-resistant Staphylococcus aureus in patients undergoing elective orthopaedic surgery. JBone Joint Surg Am 2010, 92(9):1820-1826.
39. Perl T.M., Cullen J.J., Wenzel R.P., et al. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. NEngl J Med 2002, 346(24):1871-1877.
40. Kalmeijer M.D., van Nieuwland-Bollen E., Bogaers-Hofman D., de Baere G.A. Nasal carriage of Staphylococcus aureus is a major risk factor for surgical-site infections in orthopedic surgery. Infect Control Hosp Epidemiol 2000, 21(5):319-323.
41. Muñoz P., Hortal J., Giannella M., et al. Nasal carriage of Saureus increases the risk of surgical site infection after major heart surgery. JHosp Infect 2008, 68(1):25-31.
42. Levy P.Y., Ollivier M., Drancourt M., Raoult D., Argenson J.N. Relation between nasal carriage of Staphylococcus aureus and surgical site infection in orthopedic surgery: the role ofnasal contamination. A systematic literature review andmeta-analysis. Orthop Traumatol Surg Res 2013, 99(6):645-651.
43. Chen A.F., Heyl A.E., Xu P.Z., Rao N., Klatt B.A. Preoperative decolonization effective at reducing staphylococcal colonization in total joint arthroplasty patients. J Arthroplasty 2013, 28(8 Suppl):S18-S20.
44. Jarvis W.R., Jarvis A.A., Chinn R.Y. National prevalence of methicillin-resistant Staphylococcus aureus in inpatients at United States health care facilities, 2010. Am J Infect Control 2012, 40(3):194-200.
45. Ramirez M.C., Marchessault M., Govednik-Horny C., Jupiter D., Papaconstantinou H.T. The impact of MRSA colonization on surgical site infection following major gastrointestinal surgery. JGastrointest Surg 2013, 17(1):144-152.
46. Kluytmans J.A., Mouton J.W., VandenBergh M.F., et al. Reduction of surgical-site infections in cardiothoracic surgery by elimination of nasal carriage of Staphylococcus aureus. Infect Control Hosp Epidemiol 1996, 17(12):780-785.
47. VandenBergh M.F., Kluytmans J.A., van Hout B.A., et al. Cost-effectiveness of perioperative mupirocin nasal ointment in cardiothoracic surgery. Infect Control Hosp Epidemiol 1996, 17(12):786-792.
48. Gernaat-van der Sluis A.J., Hoogenboom-Verdegaal A.M., Edixhoven P.J., Spies-van Rooijen N.H. Prophylactic mupirocin could reduce orthopedic wound infections. 1,044 patients treated with mupirocin compared with 1,260 historical controls. Acta Orthop Scand 1998, 69(4):412-414.
49. Kalmeijer M.D., Coertjens H., van Nieuwland-Bollen P.M., et al. Surgical site infections in orthopedic surgery: the effect of mupirocin nasal ointment in a double-blind, randomized, placebo-controlled study. Clin Infect Dis 2002, 35(4):353-358.
50. How-to guide: prevent surgical site infection for hip and knee arthroplasty. Institute for Healthcare Improvement. Accessed September 19,2014. http://www.ihi.org/resources/Pages/Tools/HowtoGuidePreventSSIforHipKneeArthroplasty.aspx.
51. Anderson D.J., Kaye K.S., Classen D., et al. Strategies to prevent surgical site infections in acute care hospitals. Infect Control Hosp Epidemiol 2008, 2(9 Suppl 1):51-61.
52. Edmiston C.E., Bruden B., Rucinski M.C., Henen C., Graham M.B., Lewis B.L. Reducing the risk of surgical site infections: does chlorhexidine gluconate provide a risk reduction benefit?. Am J Infect Control 2013, 41(Suppl):549-555.
53. Crowley D.J., Kanakaris N.K., Giammoudis P.V. Irrigation of the wounds in open fractures. JBone Joint Surg 2007, 89B:580-585.
54. Koyonos L., Zmistowski B., Della Valle C.J., Parvizi J. Infection control rate of irrigation and debridement for periprosthetic joint infection. Clin Orthop Relat Res 2011, 469(11):3043-3048.
55. Barnes S., Spencer M., Graham D., Johnson H.B. Surgical wound irrigation: a call for evidence-based standardization of practice. Am J Infect Control 2014, 42(5):525-529.
56. Vilijanto J. Disinfection of surgical wounds without inhibition of normal wound healing. Arch Surg 1980, 115(3):253-256.
57. Lineaweaver W., McMorris S., Soucy D., Howard R. Cellular and bacterial toxicity of topical antimicrobials. Plast Reconstr Surg 1985, 75(3):394-396.
58. Cheng M.T., Chang M.C., Wang S.T., Yu W.K., Liu C.L., Chen T.H. Efficacy of dilute betadine solution irrigation in the prevention of postoperative infection of spinal surgery. Spine 2005, 30(15):1689-1693.
59. Best A.J., Nixon M.F., Taylor G.J. Brief exposure of 0.05% chlorhexidine does not impair non-osteoarthritic human cartilage metabolism. JHosp Infect 2007, 67(1):67-71.
60. Hasanadka R., Seabrook G.R., Edmiston C.E. Vascular graft infections. Critical Care Infectious Diseases 2007, 531-542. Kluwer Academic Publishers, Boston, MA. 2nd ed. J. Rello, J. Vanes, M. Kollef (Eds.).
61. Surgical Care Improvement Project. Surgery patients with appropriate hair removal. The Joint Commission. Accessed September 19,2014. http://www.jointcommission.org/assets/1/6/HIQR_SpecsManual_v4_2b_PDF4.zip.
62. Recommended practices for preoperative patient skinantisepsis. Perioperative Standards and Recommended Practices 2014, e57-e80. AORN, Inc, Denver, CO.
63. Surgical site infection. National Institute for Health and Care Excellence. Accessed July 14,2014. https://www.nice.org.uk/Guidance/QS49.